From advances in diabetes research to record approval of drugs to treat rare diseases, taxpayer funded research and the effective employment of regulatory tools played a significant role in improving the health and wellbeing of Americans in 2014. Below is a year-end roundup of research highlights and scientific achievements from the National Institutes of Health, Centers for Disease Control and Prevention, National Science Foundation, Food and Drug Administration and Agency for Healthcare Research and Quality.
- NIH 2014 Research Highlights
- CDC Year in Review: “Mission Critical”
- NSF Discoveries
- FDA’s 2014 Drug Approvals: Speeding Novel Drugs to Patients Who Need Them
- AHRQ 2014 Impact Case studies
To fuel this momentum in scientific discovery and development, policymakers must commit to robust funding for the federal health agencies and policies that support private sector innovation. Take action today and tell your elected officials to make research for health a higher national priority in the 114th Congress.
The tiny increases included in the “Cromnibus” bill for the National Institutes of Health (NIH) and our nation’s other health research agencies are just that. The underwhelming support for the NIH, the Centers for Disease Control and Prevention, the National Science Foundation and the Food and Drug Administration following years of stagnant funding and budget cuts begs the question – how low can we go, given health threats the likes of which stand to bankrupt the nation? And the decision to flat-fund the Agency for Healthcare Research and Quality does not provide what it takes to reduce the much-complained of inefficiencies in our health care system. The pain and economic drain of one disease alone – Alzheimer’s – is not going to be effectively confronted without stronger investments in research. Every American who wants to see our nation overcome health threats, create jobs and shore up our economy for sustained prosperity must make it clear to the next Congress that it can and must do more, making research and innovation a strategic national priority.
World AIDS day, commemorated each year on Dec 1, aims to raise awareness about the virus, encourage advocates to redouble efforts to fight the epidemic, and remember those who have died and continue to suffer from the disease.
The 2014 World AIDS day theme “Focus, Partner, Achieve: An AIDS-free Generation,” speaks to how combined efforts and collaborations can bring us closer to a cure or vaccine. For example, public and private-sector funded research led to the development of Highly Active Antiretroviral Therapy (HAART), which revolutionized the battle against HIV/AIDS according to Research!America’s HIV/AIDS fact sheet.
Medical research has played a critical role in reducing the risk of transmission and has led to new drugs that have transformed HIV/AIDS from a fatal to a chronic illness for millions worldwide. Patients like Maria Davis, professional entertainer and HIV/AIDS advocate, has benefited from advances in HIV/AIDS treatments.
Research!America member, amfAR, The Foundation for AIDS research and The Centers for Disease Control and Prevention are raising awareness on World AIDS Day by providing up-to-date resources and information describing the human and economic impact of HIV/AIDS. In FY14, U.S. federal funding to combat HIV/AIDS here and abroad and assist those affected by the disease totaled $29.5 billion, but more resources and funding are needed to tackle this global epidemic. Tell Congress that we need more funding for HIV/AIDS research today!
To find out more about the events happening on Dec. 1, visit http://aids.gov/
In honor of Public Health Thank You Day, we will be highlighting public health professionals throughout the day. Our fourth professional today: Dinorah Lissette Calles, Ph.D., M.P.H., lieutenant at the United States Public Health Service (USPHS) and epidemic intelligence service (EIS) officer (Class of 2013) at the Centers for Disease Control and Prevention, assigned to North Dakota.
I love the interdisciplinarity of public health. As an epidemiologist, understanding culture, values, beliefs and population behavior is fundamental to the understanding of multilevel determinants of health and knowing what information to gather, how to gather it and how to process and disseminate it. In my research to date, I have drawn from disciplines such as anthropology, history, psychology and education studies to apply appropriate field research and analytical methodologies. While epidemiology is of course rigorous and quantitative in methods, it also calls for a measure of creativity in design and application of methodology, rendering it a fascinating discipline. The service aspect of public health is also incredibly rewarding. At the end of the day, knowing that one’s work has the potential for impacting a community’s or population’s well-being is a tremendous privilege.
What has been the most rewarding component of your current position as an EIS officer?
An EIS assignment to a state health department allows for work in a broad range of health events, and having the opportunity to serve in diverse settings and in rich collaborations at all levels of public health – local, state, tribal, federal and international – has been nothing short of amazing. In my first year, I responded to a large healthcare — associated outbreak, coordinated a large multi-agency health screening event in an American Indian reservation, assisted in a state-level evaluation of a vaccine-preventable disease, worked in partnership with a large county to interview Hispanic community members about health beliefs and behaviors, among other projects. That my work has informed public health practice at the local and state level is humbling. Continue reading →
In honor of Public Health Thank You Day we will be highlighting public health professionals throughout the day. Our second professional today is Andrew Hennenfent, D.V.M., M.P.H., a CDC/CSTE applied epidemiology fellow at the District of Columbia Department of Health.
What drew you to a career in public health?
After being accepted to veterinary school during my senior year of college, I attended a presentation given by the director of the DVM/MPH joint degree program at the University of Illinois College of Veterinary Medicine which centered on the critical role that veterinarians play in public health. During the presentation, the speaker described the unique perspective veterinarians contribute to public health through their understanding of herd health dynamics and the pathogenesis of current and emerging zoonotic diseases. Growing up on a multigenerational family farm in western Illinois, I had already gained firsthand knowledge of these health issues and liked the idea of integrating my production animal background and future veterinary training into the field of public health with the ability to someday address health issues that have broad impacts on multiple species.
What do you enjoy most about your current position as an early career public health professional?
As a newly appointed CDC/CSTE Applied Epidemiology Fellow in infectious disease at the District of Columbia Department of Health, I enjoy the daily challenge of dealing with both animal and human based health concerns. Working at a local health department gives me the opportunity to interact with the general public on a regular basis through both disease investigations and wellness initiatives that address challenges as they arise. Since all response starts locally, it is rewarding to see the programs and projects I contribute to directly impact and improve the lives of the intended community groups. Continue reading →
In honor of Public Health Thank You Day we will be highlighting public health professionals throughout the day today. Our first professional is Sasha McGee, Ph.D., M.P.H., epidemic intelligence service officer at the Centers for Disease Control and Prevention, assigned to the District of Columbia Department of Health.
My earliest educational and research experiences were guided by my passion to pursue a career in which my work would contribute to the improvement of health. After completing my doctoral training, I knew that I did not just want to conduct research but to participate in the translation of data into interventions that would benefit large populations. The field of public health seemed to be the perfect choice in terms of having the opportunity to both investigate and address health challenges.
What do you enjoy most about your current position as an early career public health professional?
What I enjoy most about my current position is the opportunity to participate in projects on a wide range of topics — I am always learning something new and no day is ever the same. I also appreciate the collaborative nature of my work. Continue reading →
Please join Research!America and leading U.S. public health organizations on Monday, Nov. 24, to celebrate Public Health Thank You Day, a chance to recognize public health professionals who work round-the-clock to protect the health of all Americans.
In order to facilitate your participation in Public Health Thank You Day, we have provided an online toolkit on the Public Health Thank You Day site. We encourage you to use these materials to issue your own press release, submit a letter to the editor, offer a certificate of thanks, share social media posts (#PHTYD) and more.
This year, in addition to thanking all public health heroes, we are highlighting the special roles of health professionals in our community, to salute those individuals who advance public health at all levels. We invite you to learn about the many careers which support public health, and join with us in calling attention to these extraordinary individuals.
Thank you for your ongoing participation in Public Health Thank You Day. If you participate on Monday, Nov. 24, please share your activities with us at email@example.com!
The Centers for Disease Control and Prevention (CDC) sent more than 50 disease detectives and other highly trained experts to West Africa to battle Ebola. While here in the U.S., more than 350 CDC staff are working on logistics, communications, analytics, management and other functions to support the response 24/7 at CDC’s Emergency Operations Center.“We are fulfilling our promise to the people of West Africa, Americans, and the world, that CDC would quickly ramp up its efforts to help bring the worst Ebola outbreak in history under control,” said CDC Director Tom Frieden, MD, MPH. “We know how to stop Ebola. It won’t be easy or fast, but working together with our U.S. and international partners and country leadership, together we are doing it.” Read more here.
Meanwhile, researchers at the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID) are studying Ebola and seeking better ways to diagnose and treat the disease. In 2013, the NIAID reported spending $42.49 million on Ebola research. Public-private partnerships are critical to containing and preventing such deadly outbreaks. The NIAID is collaborating with Okairos, a biotech company, to develop Ebola vaccines. The NIH is working with the drugmaker Mapp Biopharmaceutical to scale up production of its Ebola drug Zmapp and partnering with BioCryst to advance the company’s experimental treatments.
Sustained and robust federal funding is needed to respond to global health threats, and to support the development of vaccines to combat Ebola and other deadly diseases. Policymakers must assign a higher priority to medical research to ensure the health and wellness of Americans.
Click here to urge your representatives to support increased funding for federal health agencies in FY15.